Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Retained Earnings (2019 - 2026)

BioScience Health Innovations has reported Retained Earnings over the past 8 years, most recently at $71100.0 for Q1 2026.

  • Quarterly Retained Earnings fell 17.05% to $71100.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $71100.0 through Mar 2026, down 17.05% year-over-year, with the annual reading at $301007.0 for FY2025, 188.25% up from the prior year.
  • Retained Earnings was $71100.0 for Q1 2026 at BioScience Health Innovations, down from $301007.0 in the prior quarter.
  • Over five years, Retained Earnings peaked at $543419.0 in Q2 2025 and troughed at -$481464.0 in Q1 2024.
  • The 5-year median for Retained Earnings is -$146317.0 (2022), against an average of -$110930.5.
  • Year-over-year, Retained Earnings crashed 278.51% in 2022 and then skyrocketed 252.3% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$146317.0 in 2022, then tumbled by 192.57% to -$428083.0 in 2023, then increased by 20.32% to -$341083.0 in 2024, then surged by 188.25% to $301007.0 in 2025, then crashed by 76.38% to $71100.0 in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Retained Earnings are $71100.0 (Q1 2026), $301007.0 (Q4 2025), and $534637.0 (Q3 2025).